M
M. Lagos
Researcher at Valparaiso University
Publications - 7
Citations - 668
M. Lagos is an academic researcher from Valparaiso University. The author has contributed to research in topics: Latin Americans & Antibody. The author has an hindex of 5, co-authored 7 publications receiving 578 citations. Previous affiliations of M. Lagos include Clínica Alemana.
Papers
More filters
Journal ArticleDOI
Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
Satoshi Okada,Satoshi Okada,Janet Markle,Elissa K. Deenick,Elissa K. Deenick,Federico Mele,Dina Averbuch,M. Lagos,M. Lagos,Mohammed Alzahrani,Saleh Al-Muhsen,Rabih Halwani,Cindy S. Ma,Cindy S. Ma,Natalie Wong,Claire Soudais,Lauren A. Henderson,Hiyam Marzouqa,Jamal Shamma,Marcela Gonzalez,Rubén Martínez-Barricarte,Chizuru Okada,Danielle T. Avery,Daniela Latorre,Caroline Deswarte,Caroline Deswarte,Fabienne Jabot-Hanin,Fabienne Jabot-Hanin,Egídio Torrado,Jeffrey J. Fountain,Aziz Belkadi,Aziz Belkadi,Yuval Itan,Bertrand Boisson,Mélanie Migaud,Mélanie Migaud,Cecilia S. Lindestam Arlehamn,Alessandro Sette,Sylvain Breton,James McCluskey,Jamie Rossjohn,Jamie Rossjohn,Jamie Rossjohn,Jean-Pierre de Villartay,Despina Moshous,Sophie Hambleton,Sylvain Latour,Peter D. Arkwright,Capucine Picard,Olivier Lantz,Dan Engelhard,Masao Kobayashi,Laurent Abel,Laurent Abel,Laurent Abel,Andrea M. Cooper,Luigi D. Notarangelo,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Anne Puel,Anne Puel,Anne Puel,Federica Sallusto,Jacinta Bustamante,Stuart G. Tangye,Stuart G. Tangye,Jean-Laurent Casanova +67 more
TL;DR: People with loss-of-function mutations in the transcription factor RORC exhibit a surprising susceptibility to Mycobacterium, whereas inborn errors of interferon-γ (IFN-γ) immunity underlie mycobacterial disease.
Journal ArticleDOI
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
Cristina Woellner,E. Michael Gertz,Alejandro A. Schäffer,M. Lagos,Mario Perro,Erik-Oliver Glocker,Maria Cristina Pietrogrande,Fausto Cossu,José Luis Franco,Núria Matamoros,Barbara Pietrucha,Edyta Heropolitańska-Pliszka,Mehdi Yeganeh,Mostafa Moin,Teresa Espanol,Stephan Ehl,Andrew R. Gennery,Mario Abinun,Anna Bręborowicz,Tim Niehues,Sara Sebnem Kilic,Anne K. Junker,Stuart E. Turvey,Alessandro Plebani,Berta Sánchez,Ben Zion Garty,Claudio Pignata,Caterina Cancrini,Jiri Litzman,Ozden Sanal,Ulrich Baumann,Rosa Bacchetta,Amy P. Hsu,Joie Davis,Lennart Hammarström,E. Graham Davies,Efrem Eren,Peter D. Arkwright,Jukka S. Moilanen,Dorothee Viemann,Sujoy Khan,László Maródi,Andrew J. Cant,Alexandra F. Freeman,Jennifer M. Puck,Steven M. Holland,Bodo Grimbacher +46 more
TL;DR: Diagnostic guidelines for STAT3-deficient HIES are proposed based on a machine-learning approach to identify which features best predict a STAT3 mutation.
Journal ArticleDOI
Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
Journal ArticleDOI
Critical issues and needs in management of primary immunodeficiency diseases in Latin America
Antonio Condino-Neto,José Luis Franco,Claudia M. Trujillo-Vargas,Francisco J. Espinosa-Rosales,Lily E. Leiva,F. Rodriguez-Quiroz,A. King,M. Lagos,Matías Oleastro,Liliana Bezrodnik,Anete Sevciovic Grumach,Beatriz Tavares Costa-Carvalho,Ricardo U. Sorensen +12 more
TL;DR: In this paper, experts from six Latin American countries met to discuss critical issues and needs in the diagnosis and management of primary immunodeficiency diseases (PIDD) in the region, and additional collaboration across countries appears feasible in at least two areas: a laboratory network to facilitate the diagnosis of PIDD, and educational programs to improve PIDD awareness.
SERIES: PRIMARY IMMUNODEFICIENCY DISEASES IN LATIN AMERICA Critical issues and needs in management of primary immunodeficiency diseases in Latin America
TL;DR: Experts from six Latin American countries met to discuss critical issues and needs in the diagnosis and management of primary immunodeficiency diseases (PIDD), and additional collaboration across countries appears feasible in at least two areas: a laboratory network to facilitate the diagnosis of PIDD and educational programmes to improve PIDD awareness.